Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Eli Lilly and Company
M.D. Anderson Cancer Center
Inspirna, Inc.
EpicentRx, Inc.
Dana-Farber Cancer Institute
AbbVie
Amgen
University of California, San Francisco